Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
702
+2
+0.3% +$685 0.17% 42
2026
Q1
$246K Sell
700
-1
-0.1% -$356 0.16% 40
2025
Q4
$229K Buy
701
+2
+0.3% +$634 0.16% 42
2025
Q3
$197K Sell
699
-50
-7% -$14.5K 0.13% 41
2025
Q2
$209K Buy
749
+1
+0.1% +$283 0.14% 37
2025
Q1
$233K Buy
748
+5
+0.7% +$1.48K 0.19% 37
2024
Q4
$194K Buy
+743
New +$220K 0.13% 41

Other funds holding AMGN

Redwood Park Advisors's AMGN Position: Q2 2026 in Review

Redwood Park Advisors increased its Amgen (AMGN) stake by 0.29% in Q2 2026, buying an estimated $685 and bringing the position to 702 shares worth $254K. The position accounts for 0.17% of the portfolio, ranked #42.

Redwood Park Advisors first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Redwood Park Advisors held 702 shares of Amgen worth $254K as of Q2 2026.
  • Redwood Park Advisors bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.17% of Redwood Park Advisors's portfolio in Q2 2026, its #42 holding.
  • Redwood Park Advisors first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Redwood Park Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.